Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: Octreotide scan as a new diagnostic and follow-up modality - Twocase reports

Thymic carcinoid tumours constitute less than 1% of all carcinoids, and dif fer markedly from true thymomas in natural history, morphology, prognosis a nd therapeutic options. New clinical and diagnostic modalities are describe d in two brothers with thymic carcinoid associated with multiple endocrine neoplasia syndrome. Octreotide scintigraphy proved useful for diagnosis and follow-up, and somatostatin receptor positivity may provide new prospects for treatment of non-resectable or recurrent tumour.